Reply to M.A. Slavin et al

J Clin Oncol. 2019 May 1;37(13):1140-1141. doi: 10.1200/JCO.18.02227. Epub 2019 Mar 7.

Authors

Randy A Taplitz¹, Erin B Kennedy¹, Christopher R Flowers¹

Affiliation

¹ Randy A. Taplitz, MD, University of California, San Diego, San Diego, CA; Erin B. Kennedy, MHSc, American Society of Clinical Oncology, Alexandria, VA; and Christopher R. Flowers, MD, Emory University, Atlanta, GA.

PMID: 30844317
DOI: 10.1200/JCO.18.02227

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Anti-Infective Agents*
Humans
Immunologic Deficiency Syndromes*
Neoplasms*

Substances

Anti-Bacterial Agents
Anti-Infective Agents